Pressmeddelande -

BioGaia at ESPGHAN 2010

Probiotics in paediatrics: from evolution to clinical practice

European Society for Paediatric Gastroenterology Hepatology and Nutrition (ESPGHAN) Thursday June 10, 2010 Istanbul Convention & Exhibition Centre, Turkey

BioGaia will host a satellite symposium with the title “Probiotics in paediatrics: from evolution to clinical practice” on June 10. The symposium will present the latest clinical data on L. reuteri Protectis and the latest opinion on probiotics in paediatrics.

The Symposium is part of the 43rd Annual Meeting of the European Society for Paediatric Gastroenterology Hepatology and Nutrition (ESPGHAN). The latest opinons on the use of probiotics in paediatrics and new clinical data on Lactobacillus reuteri Protectis will be presented.

The Symposium will be chaired by Yvan Vandenplas, MD, PhD, Professor of Paediatrics, University Children’s Hospital, Brussels, Belgium.


Jens Walter, PhD, Assistant Professor, Department of Food Science and Technology, University of Nebraska, USA

José Saavedra, MD, PhD, Assoc. Professor of Paediatric Gastroenterology and Nutrition, Johns Hopkins University School of Medicine, USA

Francesco Savino, MD, PhD, Department of Paediatrics, Regina Margherita Hospital, University of Turin, Italy

43rd Annual Meeting of ESPGHAN

Date: Thursday June 10, 2010

Time: 07:00 – 08:30

Place: Topkapi hall, Istanbul Convention & Exhibition Centre


07:00 – 07:10 Introduction Yvan Vandenplas

07:10 – 07:30 The importance of the gastrointestinal microbiota: an evolutionary perspective Jens Walter

07:30 – 07:50 Evolution of the probiotic concept in paediatrics José Saavedra

07:50 – 08:10 Probiotics and infantile colic Francesco Savino

08:10 – 08:30 Discussion and closing remarks


  • Medicinsk forskning


  • probiotics
  • symposium


  • Utanför Sverige

BioGaia is a innovative Swedish biotechnology company, world leader in probiotics, that develops and sells probiotic products and solutions that promote people’s health. Our products combine the well researched probiotic bacteria Lactobacillus reuteri (L. reuteri) and top of the line engineering to develop one of a kind delivery systems that match consumer needs. L. reuteri is a “good” and friendly bacterium that helps battle the “bad” micro-organisms in the digestive tract improving the host's health.


Peter Rothschild

Presskontakt Verkställande direktör +46 (0)8 555 293 20